First Horizon Advisors’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $36.6K | Sell |
1,792
-18
| -1% | -$368 | ﹤0.01% | 1166 |
|
2025
Q1 | $36.2K | Sell |
1,810
-200
| -10% | -$4K | ﹤0.01% | 1075 |
|
2024
Q4 | $53.6K | Sell |
2,010
-60
| -3% | -$1.6K | ﹤0.01% | 920 |
|
2024
Q3 | $59K | Sell |
2,070
-5,783
| -74% | -$165K | ﹤0.01% | 913 |
|
2024
Q2 | $171K | Hold |
7,853
| – | – | 0.01% | 543 |
|
2024
Q1 | $174K | Hold |
7,853
| – | – | 0.01% | 537 |
|
2023
Q4 | $169K | Sell |
7,853
-250
| -3% | -$5.4K | 0.01% | 523 |
|
2023
Q3 | $137K | Buy |
8,103
+672
| +9% | +$11.4K | 0.01% | 551 |
|
2023
Q2 | $102K | Buy |
7,431
+442
| +6% | +$6.06K | ﹤0.01% | 639 |
|
2023
Q1 | $159K | Buy |
6,989
+18
| +0.3% | +$409 | 0.01% | 523 |
|
2022
Q4 | $164K | Sell |
6,971
-257
| -4% | -$6.05K | 0.01% | 496 |
|
2022
Q3 | $188K | Buy |
7,228
+6,682
| +1,224% | +$174K | 0.01% | 450 |
|
2022
Q2 | $11K | Sell |
546
-52
| -9% | -$1.05K | ﹤0.01% | 1532 |
|
2022
Q1 | $27K | Buy |
598
+138
| +30% | +$6.23K | ﹤0.01% | 808 |
|
2021
Q4 | $19K | Sell |
460
-101
| -18% | -$4.17K | ﹤0.01% | 1294 |
|
2021
Q3 | $37K | Buy |
561
+179
| +47% | +$11.8K | ﹤0.01% | 1028 |
|
2021
Q2 | $28K | Buy |
382
+111
| +41% | +$8.14K | ﹤0.01% | 986 |
|
2021
Q1 | $18K | Sell |
271
-61
| -18% | -$4.05K | ﹤0.01% | 1105 |
|
2020
Q4 | $22K | Buy |
332
+149
| +81% | +$9.87K | ﹤0.01% | 863 |
|
2020
Q3 | $9K | Buy |
+183
| New | +$9K | ﹤0.01% | 1029 |
|